Jama Pitman - Dec 12, 2023 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc. (DCPH)

Role: Title: SVP, Regulatory, Quality, & Portfolio Management
Signature: /s/ Jeffrey M. Held, Attorney-in-Fact
Stock symbol: DCPH
Transactions as of: Dec 12, 2023
Transactions value $: -$25,540
Form type: 4
Date filed: 12/14/2023, 04:05 PM
Previous filing: Oct 31, 2023
Next filing: Jan 18, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DCPH	Common Stock	Award		+5.58K	+11.55%		53.9K	Dec 12, 2023	Direct	F1
transaction	DCPH	Common Stock	Sale	-$25.5K	-1.66K	-3.09%	$15.37	52.2K	Dec 13, 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 15, 2023, the Reporting Person was granted restricted stock units ("RSUs"), which vest upon the satisfaction of three performance criteria. On December 12, 2023, the Issuer's Compensation Committee confirmed that performance criteria one had been met, resulting in the vesting of 5,576 RSUs.
F2	This sale was to cover tax liabilities in the vesting of RSUs.

Remarks:

Title: SVP, Regulatory, Quality, & Portfolio Management